Literature DB >> 1182475

Intravenous diazoxide in treatment of hypertension associated with recent myocardial infarction.

K P O'Brien, R R Grigor, P M Taylor.   

Abstract

Twenty patients with blood pressure over 180/110 mm Hg one hour after admission to a coronary care unit with recent acute myocardial infarction were given intravenous diazoxide in a bolus of 300 mg. The average blood pressure before diazoxide was 194/122 mm Hg. Blood pressure fell considerably in all patients, though six patients required two injections. The average fall was 58 mm Hg systolic and 40 mm Hg diastolic. No patient became severely hypotensive. The heart rate increased by an average of 10 beats/min. In nine patients the electrocardiographic changes immediately after the administration of diazoxide suggested an increase in myocardial injury. Though none of the patients seemed to deteriorate clinically from the diazoxide the electrocardiographic changes suggested that the use of intravenous diazoxide to lower blood pressure in patients with acute myocardial infarction might possibly be deleterious.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1182475      PMCID: PMC1674936          DOI: 10.1136/bmj.4.5988.74

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  8 in total

1.  THE SYSTEMIC AND CORONARY HEMODYNAMIC EFFECTS OF DIAZOXIDE.

Authors:  G G ROWE; T R LEICHT; W C BOAKE; J C KYLE; C W CRUMPTON
Journal:  Am Heart J       Date:  1963-11       Impact factor: 4.749

2.  Improved left ventricular function during nitroprusside infusion in acute myocardial infarction.

Authors:  J A Franciosa; C J Limas; N H Guiha; E Rodriguera; J N Cohn
Journal:  Lancet       Date:  1972-03-25       Impact factor: 79.321

3.  Serial plasma adrenaline and noradrenaline levels in myocardial infarction using a new double isotope technique.

Authors:  D C Siggers; C Salter; D C Fluck
Journal:  Br Heart J       Date:  1971-11

4.  Use of phentolamine in acute myocardial infarction associated with hypertension and left ventricular failure.

Authors:  D T Kelly; C E Delgado; D R Taylor; B Pitt; R S Ross
Journal:  Circulation       Date:  1973-04       Impact factor: 29.690

5.  Cardiac rupture during myocardial infarction. A review of 44 cases.

Authors:  F Naeim; L M De la Maza; S L Robbins
Journal:  Circulation       Date:  1972-06       Impact factor: 29.690

6.  Some effects of the hypotensive drug diazoxide on the cardiovascular system.

Authors:  W G Nayler; I McInnes; J B Swann; D Race; V Carson; T E Lowe
Journal:  Am Heart J       Date:  1968-02       Impact factor: 4.749

7.  The effect of diazoxide on coronary blood flow.

Authors:  J C Scott; A W Cowley
Journal:  Am J Cardiol       Date:  1969-12       Impact factor: 2.778

8.  Factors influencing infarct size following experimental coronary artery occlusions.

Authors:  P R Maroko; J K Kjekshus; B E Sobel; T Watanabe; J W Covell; J Ross; E Braunwald
Journal:  Circulation       Date:  1971-01       Impact factor: 29.690

  8 in total
  7 in total

Review 1.  Hypertensive emergencies and urgencies: definition, recognition, and management.

Authors:  J B Reuler; G J Magarian
Journal:  J Gen Intern Med       Date:  1988 Jan-Feb       Impact factor: 5.128

Review 2.  Adverse effects of antihypertensive drugs.

Authors:  F E Husserl; F H Messerli
Journal:  Drugs       Date:  1981-09       Impact factor: 9.546

Review 3.  Multiplicity of effectors of the cardioprotective agent, diazoxide.

Authors:  William A Coetzee
Journal:  Pharmacol Ther       Date:  2013-06-19       Impact factor: 12.310

4.  Treatment of hypertension in acute stage of myocardial infarction. Haemodynamic effects of labetalol.

Authors:  M Renard; A Rivière; P Jacobs; R Bernard
Journal:  Br Heart J       Date:  1983-06

5.  Use of a simulation model to study the acute haemodynamic effects of diazoxide in man.

Authors:  A O Brubakk; J Bathen
Journal:  Eur J Clin Pharmacol       Date:  1979-03-26       Impact factor: 2.953

6.  Labetalol infusion in acute myocardial infarction with systemic hypertension.

Authors:  P G Marx; D S Reid
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

7.  Blood pressure reduction by incremental infusion of labetalol in patients with severe hypertension.

Authors:  A M Cummings; J J Brown; R Fraser; A F Lever; J J Morton; D A Richards; J I Robertson
Journal:  Br J Clin Pharmacol       Date:  1979-10       Impact factor: 4.335

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.